Xiaoqing Peng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xiaoqing Peng has a total of 80 co-authors. Here are the top co-authors by number of shared publications:
- Jianxin Wang
School of Computer Science and Engineering, Central South University, Changsha, Hunan, China
8 shared publications Wanxin Cui
Hunan Key Laboratory of Bioinformatics, School of Computer Science and Engineering, Central South University, Changsha, China
5 shared publicationsWenlong Jie
Hunan Key Laboratory of Bioinformatics, School of Computer Science and Engineering, Central South University, LuShan Nan Road 932, Changsha, 410083, Hunan, China
5 shared publicationsJianxin Wang
School of Computer Science and Engineering, Central South University, Changsha 410083, China
4 shared publicationsWenjin Zhang
Center for Medical Genetics & Hunan Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Changsha, China
4 shared publicationsXiangyan Kong
School of Computer Science and Engineering, Central South University, Changsha, 410083, China
4 shared publications
Latest Publications
- 13 April 2025
- Published by Springer Nature
- p. 176-185
A Personalized Teaching Assistant Platform Driven by Large Language Models of Artificial Intelligence
- 13 April 2025
- Published by Springer Nature
- p. 176-185
A Personalized Teaching Assistant Platform Driven by Large Language Models of Artificial Intelligence
- Open Access
- 23 December 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19  (12) , e0315920
DMRIntTk: Integrating different DMR sets based on density peak clustering
Background: Identifying differentially methylated regions (DMRs) is a basic task in DNA methylation analysis. However, due to the different strategies adopted, different DMR sets will be predicted on the same dataset, which poses a challenge in selecting a reliable and comprehensive DMR set for downstream analysis. Results: Here, we develop DMRIntTk, a toolkit for integrating DMR sets predicted by different methods on a same dataset. In DMRIntTk, the genome is segmented into bins, and the reliability of each DMR set at different methylation thresholds is evaluated. Then, the bins are weighted based on the covered DMR sets and integrated into final DMRs using a density peak clustering algorithm. To demonstrate the practicality of DMRIntTk, it was applied to different scenarios, including tissues with relatively large methylation differences, cancer tissues versus normal tissues with medium methylation differences, and disease tissues versus normal tissues with subtle methylation differences. Our results show that DMRIntTk can effectively trim regions with small methylation differences from the original DMR sets and thereby enriching the proportion of DMRs with larger methylation differences. In addition, the overlap analysis suggests that the integrated DMR sets are quite comprehensive, and functional analyses indicate the integrated disease-related DMRs are significantly enriched in biological pathways associated with the pathological mechanisms of the diseases. A comparative analysis of the integrated DMR set versus each original DMR set further highlights the superiority of DMRIntTk, demonstrating the unique biological insights it can provide. Conclusions: Conclusively, DMRIntTk can help researchers obtain a reliable and comprehensive DMR set from many prediction methods.
- 23 December 2024
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 19  (12) , e0315920
Open AccessDMRIntTk: Integrating different DMR sets based on density peak clustering
Background: Identifying differentially methylated regions (DMRs) is a basic task in DNA methylation analysis. However, due to the different strategies adopted, different DMR sets will be predicted on the same dataset, which poses a challenge in selecting a reliable and comprehensive DMR set for downstream analysis. Results: Here, we develop DMRIntTk, a toolkit for integrating DMR sets predicted by different methods on a same dataset. In DMRIntTk, the genome is segmented into bins, and the reliability of each DMR set at different methylation thresholds is evaluated. Then, the bins are weighted based on the covered DMR sets and integrated into final DMRs using a density peak clustering algorithm. To demonstrate the practicality of DMRIntTk, it was applied to different scenarios, including tissues with relatively large methylation differences, cancer tissues versus normal tissues with medium methylation differences, and disease tissues versus normal tissues with subtle methylation differences. Our results show that DMRIntTk can effectively trim regions with small methylation differences from the original DMR sets and thereby enriching the proportion of DMRs with larger methylation differences. In addition, the overlap analysis suggests that the integrated DMR sets are quite comprehensive, and functional analyses indicate the integrated disease-related DMRs are significantly enriched in biological pathways associated with the pathological mechanisms of the diseases. A comparative analysis of the integrated DMR set versus each original DMR set further highlights the superiority of DMRIntTk, demonstrating the unique biological insights it can provide. Conclusions: Conclusively, DMRIntTk can help researchers obtain a reliable and comprehensive DMR set from many prediction methods.
- Open Access
- 20 November 2024
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 121  (48)
KCTD10 p.C124W variant contributes to schizophrenia by attenuating LLPS-mediated synapse formation
KCTD10, a member of the potassium channel tetramerization domain (KCTD) family, is implicated in neuropsychiatric disorders and functions as a substrate recognition component within the RING-type ubiquitin ligase complex. A rare de novo variant of KCTD10, p.C124W, was identified in schizophrenia cases, yet its underlying pathogenesis remains unexplored. Here, we demonstrate that heterozygous KCTD10 C124W mice display pronounced synaptic abnormalities and exhibit schizophrenia-like behaviors. Mechanistically, we reveal that KCTD10 undergoes liquid–liquid phase separation (LLPS), a process orchestrated by its intrinsically disordered region (IDR). p.C124W mutation disrupts this LLPS capability, leading to diminished degradation of RHOB and subsequent excessive accumulation in the postsynaptic density fractions. Notably, neither IDR deletion nor p.C124W mutation in KCTD10 mitigates the synaptic abnormalities caused by Kctd10 deficiency. Thus, our findings implicate that LLPS may be associated with the pathogenesis of KCTD10-associated brain disorders and highlight the potential of targeting RHOB as a therapeutic strategy for diseases linked to mutations in KCTD10 or RHOB.
- 20 November 2024
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 121  (48)
Open AccessKCTD10 p.C124W variant contributes to schizophrenia by attenuating LLPS-mediated synapse formation
KCTD10, a member of the potassium channel tetramerization domain (KCTD) family, is implicated in neuropsychiatric disorders and functions as a substrate recognition component within the RING-type ubiquitin ligase complex. A rare de novo variant of KCTD10, p.C124W, was identified in schizophrenia cases, yet its underlying pathogenesis remains unexplored. Here, we demonstrate that heterozygous KCTD10 C124W mice display pronounced synaptic abnormalities and exhibit schizophrenia-like behaviors. Mechanistically, we reveal that KCTD10 undergoes liquid–liquid phase separation (LLPS), a process orchestrated by its intrinsically disordered region (IDR). p.C124W mutation disrupts this LLPS capability, leading to diminished degradation of RHOB and subsequent excessive accumulation in the postsynaptic density fractions. Notably, neither IDR deletion nor p.C124W mutation in KCTD10 mitigates the synaptic abnormalities caused by Kctd10 deficiency. Thus, our findings implicate that LLPS may be associated with the pathogenesis of KCTD10-associated brain disorders and highlight the potential of targeting RHOB as a therapeutic strategy for diseases linked to mutations in KCTD10 or RHOB.
- Open Access
DMRIntTk: integrating different DMR sets based on density peak clustering
\textbf{Background}: Identifying differentially methylated regions (DMRs) is a basic task in DNA methylation analysis. However, due to the different strategies adopted, different DMR sets will be predicted on the same dataset, which poses a challenge in selecting a reliable and comprehensive DMR set for downstream analysis. \textbf{Results}: Here, we develop DMRIntTk, a toolkit for integrating DMR sets predicted by different methods on a same dataset. In DMRIntTk, the genome is segmented into bins and the reliability of each DMR set at different methylation thresholds is evaluated. Then, the bins are weighted based on the covered DMR sets and integrated into DMRs by using a density peak clustering algorithm. To demonstrate the practicality of DMRIntTk, DMRIntTk was applied to different scenarios, including different tissues with relatively large methylation differences, cancer tissues versus normal tissues with medium methylation differences, and disease tissues versus normal tissues with subtle methylation differences. The results show that DMRIntTk can effectively trim the regions with small methylation differences in the original DMR sets and therefore it can enhance the proportion of DMRs with higher methylation differences. In addition, the overlap analysis suggests that the integrated DMR sets are quite comprehensive, and the functional analysis indicates the integrated disease-related DMR sets are significantly enriched in biological pathways, which are associated with the pathological mechanisms of the diseases. \textbf{Conclusions}: Conclusively, DMRIntTk can help researchers obtaining a reliable and comprehensive DMR set from many prediction methods. \textbf{Keywords}:{Differentially methylated regions, Methylation array, Cancer-related differentially methylated regions, Tissue-specific differentially methylated regions, Density peak clustering.}
Open AccessDMRIntTk: integrating different DMR sets based on density peak clustering
\textbf{Background}: Identifying differentially methylated regions (DMRs) is a basic task in DNA methylation analysis. However, due to the different strategies adopted, different DMR sets will be predicted on the same dataset, which poses a challenge in selecting a reliable and comprehensive DMR set for downstream analysis. \textbf{Results}: Here, we develop DMRIntTk, a toolkit for integrating DMR sets predicted by different methods on a same dataset. In DMRIntTk, the genome is segmented into bins and the reliability of each DMR set at different methylation thresholds is evaluated. Then, the bins are weighted based on the covered DMR sets and integrated into DMRs by using a density peak clustering algorithm. To demonstrate the practicality of DMRIntTk, DMRIntTk was applied to different scenarios, including different tissues with relatively large methylation differences, cancer tissues versus normal tissues with medium methylation differences, and disease tissues versus normal tissues with subtle methylation differences. The results show that DMRIntTk can effectively trim the regions with small methylation differences in the original DMR sets and therefore it can enhance the proportion of DMRs with higher methylation differences. In addition, the overlap analysis suggests that the integrated DMR sets are quite comprehensive, and the functional analysis indicates the integrated disease-related DMR sets are significantly enriched in biological pathways, which are associated with the pathological mechanisms of the diseases. \textbf{Conclusions}: Conclusively, DMRIntTk can help researchers obtaining a reliable and comprehensive DMR set from many prediction methods. \textbf{Keywords}:{Differentially methylated regions, Methylation array, Cancer-related differentially methylated regions, Tissue-specific differentially methylated regions, Density peak clustering.}
- Open Access
DMRIntTk: integrating different DMR sets based on density peak clustering
Background Identifying differentially methylated regions (DMRs) is a basic task in DNA methylation analysis. However, due to the different strategies adopted, different DMR sets will be predicted on the same dataset, which poses a challenge in selecting a reliable and comprehensive DMR set for downstream analysis. Results Here, we develop DMRIntTk, a toolkit for integrating DMR sets predicted by different methods on a same dataset. In DMRIntTk, the genome is segmented into bins and the reliability of each DMR set at different methylation thresholds is evaluated. Then, the bins are weighted based on the covered DMR sets and integrated into DMRs by using a density peak clustering algorithm. To demonstrate the practicality of DMRIntTk, DMRIntTk was applied to different scenarios, including different tissues with relatively large methylation differences, cancer tissues versus normal tissues with medium methylation differences, and disease tissues versus normal tissues with subtle methylation differences. The results show that DMRIntTk can effectively trim the regions with small methylation differences in the original DMR sets and therefore it can enhance the proportion of DMRs with higher methylation differences. In addition, the overlap analysis suggests that the integrated DMR sets are quite comprehensive, and the functional analysis indicates the integrated disease-related DMR sets are significantly enriched in biological pathways, which are associated with the pathological mechanisms of the diseases. Conclusions Conclusively, DMRIntTk can help researchers obtaining a reliable and comprehensive DMR set from many prediction methods.
Open AccessDMRIntTk: integrating different DMR sets based on density peak clustering
Background Identifying differentially methylated regions (DMRs) is a basic task in DNA methylation analysis. However, due to the different strategies adopted, different DMR sets will be predicted on the same dataset, which poses a challenge in selecting a reliable and comprehensive DMR set for downstream analysis. Results Here, we develop DMRIntTk, a toolkit for integrating DMR sets predicted by different methods on a same dataset. In DMRIntTk, the genome is segmented into bins and the reliability of each DMR set at different methylation thresholds is evaluated. Then, the bins are weighted based on the covered DMR sets and integrated into DMRs by using a density peak clustering algorithm. To demonstrate the practicality of DMRIntTk, DMRIntTk was applied to different scenarios, including different tissues with relatively large methylation differences, cancer tissues versus normal tissues with medium methylation differences, and disease tissues versus normal tissues with subtle methylation differences. The results show that DMRIntTk can effectively trim the regions with small methylation differences in the original DMR sets and therefore it can enhance the proportion of DMRs with higher methylation differences. In addition, the overlap analysis suggests that the integrated DMR sets are quite comprehensive, and the functional analysis indicates the integrated disease-related DMR sets are significantly enriched in biological pathways, which are associated with the pathological mechanisms of the diseases. Conclusions Conclusively, DMRIntTk can help researchers obtaining a reliable and comprehensive DMR set from many prediction methods.
- 12 July 2024
- Published by Springer Nature
- p. 423-433
Noninvasive Diagnosis of Cancer Based on the Heterogeneity and Fragmentation Features of Cell-Free Mitochondrial DNA
- 12 July 2024
- Published by Springer Nature
- p. 423-433
Noninvasive Diagnosis of Cancer Based on the Heterogeneity and Fragmentation Features of Cell-Free Mitochondrial DNA
- 1 June 2024
- Published by Bentham Science Publishers Ltd. in Current Bioinformatics
- Vol. 19  (5) , 490-501
DMR_Kmeans: Identifying Differentially Methylated Regions Based on k-means Clustering and Read Methylation Haplotype Filtering
Introduction:: Differentially methylated regions (DMRs), including tissue-specific DMRs and disease-specific DMRs, can be used in revealing the mechanisms of gene regulation and screening diseases. Up until now, many methods have been proposed to detect DMRs from bisulfite sequencing data. In these methods, differentially methylated CpG sites and DMRs are usually identified based on statistical tests or distribution models, which neglect the joint methylation statuses provided in each read and result in inaccurate boundaries of DMRs. Methods:: In this paper, a method, named DMR_Kmeans, is proposed to detect DMRs based on kmeans clustering and read methylation haplotype filtering. In DMR_Kmeans, for each CpG site, the k-means algorithm is used to cluster the methylation levels from two groups, and the methylation difference of the CpG is measured based on the different distributions in clusters. Methylation haplotypes of reads are employed to extract the methylation patterns in a candidate region. Finally, DMRs are identified based on the methylation differences and the methylation patterns in candidate regions. Result:: Comparing the performance of DMR_Kmeans and eight DMR detection methods on the whole genome bisulfite sequencing data of six pairs of tissues, the results show that DMR_Kmeans achieves higher Qn and Ql, and more overlapped promoters than other methods when given a certain threshold of methylation difference greater than 0.4, which indicates that the DMRs predicted by DMR_Kmeans with accurate boundaries contain less CpGs with small methylation differences than those by other methods. Conclusion:: Furthermore, it suggests that DMR_Kmeans can provide a DMR set with high quality for downstream analysis since the total length of DMRs predicted by DMR_Kmeans is longer and the total number of CpG sites in the DMRs is greater than those of other methods.
- 1 June 2024
- Published by Bentham Science Publishers Ltd. in Current Bioinformatics
- Vol. 19  (5) , 490-501
DMR_Kmeans: Identifying Differentially Methylated Regions Based on k-means Clustering and Read Methylation Haplotype Filtering
Introduction:: Differentially methylated regions (DMRs), including tissue-specific DMRs and disease-specific DMRs, can be used in revealing the mechanisms of gene regulation and screening diseases. Up until now, many methods have been proposed to detect DMRs from bisulfite sequencing data. In these methods, differentially methylated CpG sites and DMRs are usually identified based on statistical tests or distribution models, which neglect the joint methylation statuses provided in each read and result in inaccurate boundaries of DMRs. Methods:: In this paper, a method, named DMR_Kmeans, is proposed to detect DMRs based on kmeans clustering and read methylation haplotype filtering. In DMR_Kmeans, for each CpG site, the k-means algorithm is used to cluster the methylation levels from two groups, and the methylation difference of the CpG is measured based on the different distributions in clusters. Methylation haplotypes of reads are employed to extract the methylation patterns in a candidate region. Finally, DMRs are identified based on the methylation differences and the methylation patterns in candidate regions. Result:: Comparing the performance of DMR_Kmeans and eight DMR detection methods on the whole genome bisulfite sequencing data of six pairs of tissues, the results show that DMR_Kmeans achieves higher Qn and Ql, and more overlapped promoters than other methods when given a certain threshold of methylation difference greater than 0.4, which indicates that the DMRs predicted by DMR_Kmeans with accurate boundaries contain less CpGs with small methylation differences than those by other methods. Conclusion:: Furthermore, it suggests that DMR_Kmeans can provide a DMR set with high quality for downstream analysis since the total length of DMRs predicted by DMR_Kmeans is longer and the total number of CpG sites in the DMRs is greater than those of other methods.
- Open Access
- 1 February 2024
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 40  (2)
AGImpute: imputation of scRNA-seq data based on a hybrid GAN with dropouts identification
Motivation: Dropout events bring challenges in analyzing single-cell RNA sequencing data as they introduce noise and distort the true distributions of gene expression profiles. Recent studies focus on estimating dropout probability and imputing dropout events by leveraging information from similar cells or genes. However, the number of dropout events differs in different cells, due to the complex factors, such as different sequencing protocols, cell types, and batch effects. The dropout event differences are not fully considered in assessing the similarities between cells and genes, which compromises the reliability of downstream analysis. Results: This work proposes a hybrid Generative Adversarial Network with dropouts identification to impute single-cell RNA sequencing data, named AGImpute. First, the numbers of dropout events in different cells in scRNA-seq data are differentially estimated by using a dynamic threshold estimation strategy. Next, the identified dropout events are imputed by a hybrid deep learning model, combining Autoencoder with a Generative Adversarial Network. To validate the efficiency of the AGImpute, it is compared with seven state-of-the-art dropout imputation methods on two simulated datasets and seven real single-cell RNA sequencing datasets. The results show that AGImpute imputes the least number of dropout events than other methods. Moreover, AGImpute enhances the performance of downstream analysis, including clustering performance, identifying cell-specific marker genes, and inferring trajectory in the time-course dataset. Availability and implementation: The source code can be obtained from https://github.com/xszhu-lab/AGImpute.
- 1 February 2024
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 40  (2)
Open AccessAGImpute: imputation of scRNA-seq data based on a hybrid GAN with dropouts identification
Motivation: Dropout events bring challenges in analyzing single-cell RNA sequencing data as they introduce noise and distort the true distributions of gene expression profiles. Recent studies focus on estimating dropout probability and imputing dropout events by leveraging information from similar cells or genes. However, the number of dropout events differs in different cells, due to the complex factors, such as different sequencing protocols, cell types, and batch effects. The dropout event differences are not fully considered in assessing the similarities between cells and genes, which compromises the reliability of downstream analysis. Results: This work proposes a hybrid Generative Adversarial Network with dropouts identification to impute single-cell RNA sequencing data, named AGImpute. First, the numbers of dropout events in different cells in scRNA-seq data are differentially estimated by using a dynamic threshold estimation strategy. Next, the identified dropout events are imputed by a hybrid deep learning model, combining Autoencoder with a Generative Adversarial Network. To validate the efficiency of the AGImpute, it is compared with seven state-of-the-art dropout imputation methods on two simulated datasets and seven real single-cell RNA sequencing datasets. The results show that AGImpute imputes the least number of dropout events than other methods. Moreover, AGImpute enhances the performance of downstream analysis, including clustering performance, identifying cell-specific marker genes, and inferring trajectory in the time-course dataset. Availability and implementation: The source code can be obtained from https://github.com/xszhu-lab/AGImpute.
- Open Access
- 12 July 2023
- Published by MDPI AG in Diagnostics
- Vol. 13  (14) , 2351
Characterization of Mitochondrial DNA Methylation of Alzheimer’s Disease in Plasma Cell-Free DNA
Noninvasive diagnosis of Alzheimer’s disease (AD) is important for patients. Significant differences in the methylation of mitochondrial DNA (mtDNA) were found in AD brain tissue. Cell-free DNA (cfDNA) is a noninvasive and economical diagnostic tool. We aimed to characterize mtDNA methylation alterations in the plasma cfDNA of 31 AD patients and 26 age- and sex-matched cognitively normal control subjects. We found that the mtDNA methylation patterns differed between AD patients and control subjects. The mtDNA was predominantly hypomethylated in the plasma cfDNA of AD patients. The hypomethylation sites or regions were mainly located in mt-rRNA, mt-tRNA, and D-Loop regions. The hypomethylation of the D-Loop region in plasma cfDNA of AD patients was consistent with that in previous studies. This study presents evidence that hypomethylation in the non-protein coding region of mtDNA may contribute to the pathogenesis of AD and potential application for the diagnosis of AD.
- 12 July 2023
- Published by MDPI AG in Diagnostics
- Vol. 13  (14) , 2351
Open AccessCharacterization of Mitochondrial DNA Methylation of Alzheimer’s Disease in Plasma Cell-Free DNA
Noninvasive diagnosis of Alzheimer’s disease (AD) is important for patients. Significant differences in the methylation of mitochondrial DNA (mtDNA) were found in AD brain tissue. Cell-free DNA (cfDNA) is a noninvasive and economical diagnostic tool. We aimed to characterize mtDNA methylation alterations in the plasma cfDNA of 31 AD patients and 26 age- and sex-matched cognitively normal control subjects. We found that the mtDNA methylation patterns differed between AD patients and control subjects. The mtDNA was predominantly hypomethylated in the plasma cfDNA of AD patients. The hypomethylation sites or regions were mainly located in mt-rRNA, mt-tRNA, and D-Loop regions. The hypomethylation of the D-Loop region in plasma cfDNA of AD patients was consistent with that in previous studies. This study presents evidence that hypomethylation in the non-protein coding region of mtDNA may contribute to the pathogenesis of AD and potential application for the diagnosis of AD.